Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.
Visit our Writing Guide or this topic page for additional help.
Timeline
June 9, 2020
The ALS Association and I AM ALS announces that the organizations have awarded a combined grant of $500,000 to BrainStorm Cell Therapeutics to support an amyotrophic lateral sclerosis (ALS) biomarker research study.
Patents
Further Resources
Title
Author
Link
Type
Date
News
Title
Author
Date
Publisher
Description
Annalee Armstrong
September 15, 2021
FierceBiotech
The FDA has done a U-turn on Amylyx's amyotrophic lateral sclerosis (ALS) drug AMX0035. After asking for a new phase 3 study in April, the agency will now accept the biotech's submission based on phase 2 evidence.
April 8, 2021
BioSpace
Non-profit Partnership Spurs Phase 3 Clinical Trial for Patients With Rare Genetic Form Of ALS - read this article along with other careers information, tips and advice on BioSpace
Project ALS
April 8, 2021
www.prnewswire.com:443
/PRNewswire/ -- The ALS Association and Project ALS are pleased to announce that their jointly sponsored pilot program has resulted in this week's announcement...
Staff and agencies
November 23, 2020
the Guardian
Quinn credited with boosting 'greatest social media campaign in history', raising more than $220m for ALS research
Brian Barrett
June 23, 2020
Wired
At 37, Brian Wallach was diagnosed with the fatal disease. So he tapped a lifetime of connections to give help and hope to fellow sufferers--while grappling with his own mortality.
SHOW MORE
References
Company
OrganizationCompany attributes
Nonprofit organization
Amyotrophic lateral sclerosis
Arlington County, Virginia
Washington, D.C.Legal classification
Founded Date
1985
United States